2019 saw a research & development by business enterprise, pharmaceutical industry in current ppp $ of 1,093.71 million in France, a decrease of 22.35 million (-2.0%).
Research & development by business enterprise, pharmaceutical industry in current PPP $ in France
No matching regions
Similar regions to France
Business R&D pharmaceutical in current PPP $
More indicators for France
Government R&D in security as % of government support
7.6%
+1.49%
(2021)
Higher-education-finacing R&D financed by general university in local currency
36,331.51M
-2,332.69M
(2015)
R&D financed by rest of the world in local currency
42,663.99M
+1,742.43M
(2021)
Government R&D financed by rest of the world in local currency
5,363.60M
-470.20M
(2021)
Business R&D financed by rest of the world in local currency
31,430.09M
+2,892.63M
(2021)
Non-profit R&D growth rate
-1.84%
-10.2%
(2022)
France Business R&D pharmaceutical in current PPP $ between 2007 and 2020
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2020 | 1,093.71M | -22.35M |
| 2019 | 1,116.06M | +31.79M |
| 2018 | 1,084.27M | +5.56M |
| 2017 | 1,078.71M | -9.04M |
| 2016 | 1,087.75M | -9.69M |
| 2015 | 1,097.44M | +38.67M |
| 2014 | 1,058.77M | +70.77M |
| 2013 | 988.00M | +31.35M |
| 2012 | 956.65M | -41.04M |
| 2011 | 997.69M | +22.93M |
| 2010 | 974.76M | -14.95M |
| 2009 | 989.71M | -203.23M |
| 2008 | 1,192.94M | -44.10M |
| 2007 | 1,237.04M |